Omega-3 Fatty Acids in Early Prevention of Inflammatory Neurodegenerative Disease: A Focus on Alzheimer’s Disease
Open accessThe DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
Abstract
Alzheimer’s disease (AD) is the leading cause of dementia and the most common neurodegenerative disease in the elderly. Furthermore, AD has provided the most positive indication to support the fact that inflammation contributes to neurodegenerative disease. The exact etiology of AD is unknown, but environmental and genetic factors are thought to contribute, such as advancing age, family history, presence of chronic diseases such as cardiovascular disease (CVD) and diabetes, and poor diet and lifestyle. It is hypothesised that early prevention or management of inflammation could delay the onset or reduce the symptoms of AD. Normal physiological changes to the brain with ageing include depletion of long chain omega-3 fatty acids and brains of AD patients have lower docosahexaenoic acid (DHA) levels. DHA supplementation can reduce markers of inflammation. This review specifically focusses on the evidence in humans from epidemiological, dietary intervention, and supplementation studies, which supports the role of long chain omega-3 fatty acids in the prevention or delay of cognitive decline in AD in its early stages. Longer term trials with long chain omega-3 supplementation in early stage AD are warranted. We also highlight the importance of overall quality and composition of the diet to protect against AD and dementia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Lipids provide a further advantage in that dietary intervention represents a fairly straightforward manner to achieve proper lipid homeostasis [111,112,113].”
From Alzheimer's Disease: Treatment Strategies and Their Limitations. (2022) · cites this paper as [111]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Long-chain n-3 FA supplementation in the early stages of AD has shown promising potential [111].”
From Alzheimer's Disease: Treatment Strategies and Their Limitations. (2022) · cites this paper as [111]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hearing loss and cognitive decline in older adults
Lin, F. R., Yaffe, K., Xia, J., Xue, Q.-L., Harris, T. B., Purchase-Helzner, E., Satterfield, S., Ayonayon, H. N., Ferrucci, L., Simonsick, E. M., et al. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.1868 · Cited by 4,017
Gauthier, S., Reisberg, B., Zaudig, M., Petersen, R. C., Ritchie, K., Broich, K., Belleville, S., Brodaty, H., Bennett, D., Chertkow, H., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68542-5 · Cited by 3,850
Mechanisms underlying inflammation in neurodegeneration
Glass, C. K., Saijo, K., Winner, B., Marchetto, M. C., & Gage, F. H. (2010) · Cell · doi:10.1016/j.cell.2010.02.016 · Cited by 3,580
Blennow, K., de Leon, M. J., & Zetterberg, H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69113-7 · Cited by 3,134
Diabetes mellitus and the risk of dementia: The Rotterdam Study
Ott, A., Stolk, R. P., van Harskamp, F., Pols, H. A. P., Hofman, A., & Breteler, M. M. B. (1999) · Neurology · doi:10.1212/wnl.53.9.1937 · Cited by 2,175
Adherence to Mediterranean diet and health status: meta-analysis
Sofi, F., Cesari, F., Abbate, R., Gensini, G. F., & Casini, A. (2008) · BMJ · doi:10.1136/bmj.a1344 · Cited by 1,717 · cited 1×
“[10] Meta-analysis 3 studies various (133626, various) Various Various Adherence to MD led to a 13% lower incidence of neurodegenerative diseases such as AD”
MethodSofi, F., Abbate, R., Gensini, G. F., & Casini, A. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2010.29673 · Cited by 1,605
Omega-3 fatty acids EPA and DHA: Health benefits throughout life
Swanson, D., Block, R., & Mousa, S. A. (2012) · Advances in Nutrition · doi:10.3945/an.111.000893 · Cited by 1,575 · cited 1×
“In addition to health benefits of omega-3 supplementation in other settings, a number of studies report using omega3 supplementation in (early) AD [94].”
BackgroundInnate immune activation in neurodegenerative disease
Heneka, M. T., Kummer, M. P., & Latz, E. (2014) · Nature Reviews Immunology · doi:10.1038/nri3705 · Cited by 1,437
Mediterranean diet and risk for Alzheimer's disease
Scarmeas, N., Stern, Y., Tang, M., Mayeux, R., & Luchsinger, J. A. (2006) · Annals of Neurology · doi:10.1002/ana.20854 · Cited by 1,103
Brenna, J. T., Salem, N., Sinclair, A. J., & Cunnane, S. C. (2009) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2009.01.004 · Cited by 863
Docosahexaenoic Acid Supplementation and Cognitive Decline in Alzheimer Disease: A Randomized Trial
Quinn, J. F., Raman, R., Thomas, R. G., Yurko-Mauro, K., Nelson, E. B., Van Dyck, C., Galvin, J. E., Emond, J., Jack, C. R., Weiner, M., et al. (2010) · JAMA · doi:10.1001/jama.2010.1510 · Cited by 764
Bourre, J. M. (2006) · PubMed · Cited by 752
Freund-Levi, Y., Eriksdotter-Jönhagen, M., Cederholm, T., Basun, H., Faxén-Irving, G., Garlind, A., Vedin, I., Vessby, B., Wahlund, L.-O., & Palmblad, J. (2006) · Archives of Neurology · doi:10.1001/archneur.63.10.1402 · Cited by 751
Mediterranean diet improves cognition: the PREDIMED-NAVARRA randomised trial
Martínez-Lapiscina, E. H., Clavero, P., Toledo, E., Estruch, R., Salas-Salvadó, J., San Julián, B., Sanchez-Tainta, A., Ros, E., Valls-Pedret, C., & Martinez-Gonzalez, M. Á. (2013) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-304792 · Cited by 747 · cited 1×
“There is also good evidence from epidemiological studies that a Mediterranean-style dietary pattern (rich in plant derived ALA and LC-PUFA from fish and seafood) may be protective for neurodegenerative diseases such as AD and Parkinson’s disease [99], and recent results from the Spanish PREDIMED study demonstrated imp…”
ResultLim, G. P., Calon, F., Morihara, T., Yang, F., Teter, B., Ubeda, O., Salem, N., Frautschy, S. A., & Cole, G. M. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4225-04.2005 · Cited by 686
Disturbance of endoplasmic reticulum proteostasis in neurodegenerative diseases
Hetz, C., & Mollereau, B. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3689 · Cited by 684 · cited 1×
“…3086, VIC, Australia 2Department of Rehabilitation, Nutrition and Sport, La Trobe University, Bundoora 3086, VIC, Australia Correspondence should be addressed to C. Itsiopoulos; c.itsiopoulos@latrobe.edu.au Received 26 September 2014; Revised 23 February 2015; Accepted 23 February…”
BackgroundBaker, L. D., Cross, D. J., Minoshima, S., Belongia, D., Watson, G. S., & Craft, S. (2011) · Archives of Neurology · doi:10.1001/archneurol.2010.225 · Cited by 639
Inflammatory Neurodegeneration and Mechanisms of Microglial Killing of Neurons
Brown, G. C., & Neher, J. J. (2010) · Molecular Neurobiology · doi:10.1007/s12035-010-8105-9 · Cited by 528
Conquer, J. A., Tierney, M. C., Zecevic, J., Bettger, W. J., & Fisher, R. H. (2000) · Lipids · doi:10.1007/s11745-000-0646-3 · Cited by 524
Docosahexaenoic acid: A positive modulator of Akt signaling in neuronal survival
Akbar, M., Calderon, F., Wen, Z., & Kim, H.-Y. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502903102 · Cited by 467
Daviglus, M. L., Bell, C. C., Berrettini, W., Bowen, P. E., Connolly, E. S., Cox, N. J., Dunbar-Jacob, J. M., Granieri, E. C., Hunt, G., McGarry, K., et al. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-153-3-201008030-00260 · Cited by 463 · cited 4×
“Multiple consensus documents and recent reviews [1, 2, 25] have identified that the most consistent evidence on nutrition and AD risk is for longer chain omega-3 fatty acids, primarily obtained through regular fish consumption; however recent supplementation trials are promising.”
BackgroundInfluentialDietary factors and Alzheimer's disease
Luchsinger, J. A., & Mayeux, R. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00878-6 · Cited by 433
Insulin resistance is associated with the pathology of Alzheimer disease: The Hisayama Study
Matsuzaki, T., Sasaki, K., Tanizaki, Y., Hata, J., Fujimi, K., Matsui, Y., Sekita, A., Suzuki, S. O., Kanba, S., Kiyohara, Y., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181eee25f · Cited by 432
Dietary polyunsaturated fatty acids and regulation of gene transcription
Jump, D. B. (2002) · Current Opinion in Lipidology · doi:10.1097/00041433-200204000-00007 · Cited by 429
Food Combination and Alzheimer Disease Risk: A Protective Diet
Gu, Y. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.84 · Cited by 414
Chiu, C.-C., Su, K.-P., Cheng, T.-C., Liu, H.-C., Chang, C.-J., Dewey, M. E., Stewart, R., & Huang, S.-Y. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.05.015 · Cited by 406
Dietary reference intakes for DHA and EPA
Kris-Etherton, P. M., Grieger, J. A., & Etherton, T. D. (2009) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2009.05.011 · Cited by 404
Cognitive decline and fatty acid composition of erythrocyte membranes—The EVA Study
Heude, B., Ducimetière, P., & Berr, C. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.4.803 · Cited by 363 · cited 1×
“The relationship between mental health disorder and omega-3 fatty acids has been shown by lower levels of omega-3 fatty acids in the erythrocyte membrane or plasma of the patients suffering from neurodegenerative disorder as compared with healthy people [95–97].”
ResultLong-chain n−3 PUFA: plant v. marine sources
Williams, C. M., & Burdge, G. (2006) · Proceedings of the Nutrition Society · doi:10.1079/pns2005473 · Cited by 363
Horrocks, L. A., & Farooqui, A. A. (2004) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2003.12.011 · Cited by 356 · cited 1×
“Omega-3 supplementation, DHA in particular, has also been shown to modulate gene expression at the transcription level, for example, by activating peroxisome proliferator-activated receptor (PPAR) family members [85] and the mRNA stability of several enzymes associated with glucose and lipid metabolism [86].”
BackgroundZipp, F., & Aktas, O. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.07.006 · Cited by 348
Dietary and lifestyle guidelines for the prevention of Alzheimer's disease
Barnard, N. D., Bush, A. I., Ceccarelli, A., Cooper, J., de Jager, C. A., Erickson, K. I., Fraser, G., Kesler, S., Levin, S. M., Lucey, B., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.03.033 · Cited by 339
Kitajka, K., Puskás, L. G., Zvara, Á., Hackler, L., Barceló-Coblijn, G., Yeo, Y. K., & Farkas, T. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.042698699 · Cited by 323
Luchtman, D. W., & Song, C. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.07.019 · Cited by 319
Dietary supplementation of arachidonic and docosahexaenoic acids improves cognitive dysfunction
Kotani, S., Sakaguchi, E., Warashina, S., Matsukawa, N., Ishikura, Y., Kiso, Y., Sakakibara, M., Yoshimoto, T., Guo, J., & Yamashima, T. (2006) · Neuroscience Research · doi:10.1016/j.neures.2006.06.010 · Cited by 319
Type 3 diabetes is sporadic Alzheimer׳s disease: Mini-review
de la Monte, S. M. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.06.008 · Cited by 313
Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer's disease: a case–control study
Tully, A. M., Roche, H. M., Doyle, R., Fallon, C., Bruce, I., Lawlor, B., Coakley, D., & Gibney, M. J. (2003) · British Journal of Nutrition · doi:10.1079/bjn2002804 · Cited by 309
Neuroglia in neurodegeneration
Heneka, M. T., Rodríguez, J. J., & Verkhratsky, A. (2010) · Brain Research Reviews · doi:10.1016/j.brainresrev.2009.11.004 · Cited by 301
Wu, A., Ying, Z., & Gomez-Pinilla, F. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.05.061 · Cited by 298
Fat Intake at Midlife and Risk of Dementia and Alzheimer’s Disease: A Population-Based Study
Laitinen, M. H., Ngandu, T., Rovio, S., Helkala, E.-L., Uusitalo, U., Viitanen, M., Nissinen, A., Tuomilehto, J., Soininen, H., & Kivipelto, M. (2006) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000093478 · Cited by 298
Davis, B. C., & Kris-Etherton, P. M. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/78.3.640s · Cited by 283
Bazan, N. G. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800068-jlr200 · Cited by 256
Calon, F., Lim, G. P., Morihara, T., Yang, F., Ubeda, O., Salem, N., Frautschy, S. A., & Cole, G. M. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04253.x · Cited by 243
Mechanisms of n-3 fatty acid-mediated development and maintenance of learning memory performance
Su, H.-M. (2010) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2009.11.003 · Cited by 221
Docosahexaenoic Acid Reduces Amyloid β Production via Multiple Pleiotropic Mechanisms
Grimm, M. O. W., Kuchenbecker, J., Grösgen, S., Burg, V. K., Hundsdörfer, B., Rothhaar, T. L., Friess, P., de Wilde, M. C., Broersen, L. M., Penke, B., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.182329 · Cited by 220
Lee, L. K., Shahar, S., Chin, A.-V., & Yusoff, N. A. M. (2013) · Psychopharmacology · doi:10.1007/s00213-012-2848-0 · Cited by 219
Inflammation in the early stages of neurodegenerative pathology
Khandelwal, P. J., Herman, A. M., & Moussa, C. E.-H. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.07.002 · Cited by 212
Lowering dietary linoleic acid reduces bioactive oxidized linoleic acid metabolites in humans
Ramsden, C. E., Ringel, A., Feldstein, A. E., Taha, A. Y., MacIntosh, B. A., Hibbeln, J. R., Majchrzak-Hong, S. F., Faurot, K. R., Rapoport, S. I., Cheon, Y., et al. (2012) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2012.08.004 · Cited by 192
Greiner, R. S., Moriguchi, T., Hutton, A., Slotnick, B. M., & Salem, N. (1999) · Lipids · doi:10.1007/bf02562305 · Cited by 191
de la Monte, S. M., Longato, L., Tong, M., & Wands, J. R. (2009) · PubMed · Cited by 190
DeFilippis, A. P., & Sperling, L. S. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.03.051 · Cited by 188
Ramsden, C. E., Faurot, K. R., Zamora, D., Suchindran, C. M., MacIntosh, B. A., Gaylord, S., Ringel, A., Hibbeln, J. R., Feldstein, A. E., Mori, T. A., et al. (2013) · Pain · doi:10.1016/j.pain.2013.07.028 · Cited by 186
Freund‐Levi, Y., Basun, H., Cederholm, T., Faxén‐Irving, G., Garlind, A., Grut, M., Vedin, I., Palmblad, J., Wahlund, L., & Eriksdotter‐Jönhagen, M. (2008) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1857 · Cited by 183
Larqué, E., Krauss‐Etschmann, S., Campoy, C., Hartl, D., Linde, J., Klingler, M., Demmelmair, H., Caño, Á., Gil, Á., Bondy, B., et al. (2006) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/84.4.853 · Cited by 174
Itsiopoulos, C., Brazionis, L., Kaimakamis, M., Cameron, M., Best, J. D., O’Dea, K., & Rowley, K. (2011) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2010.03.005 · Cited by 171 · cited 1×
“The traditional Mediterranean diet is characterised by an abundance of bioactive phytonutrients, with antioxidant and anti-inflammatory potential, derived from extra virgin olive oil as the main added fat, fresh fruits and leafy vegetables, legumes, wholegrain cereals, nuts and seeds, fish and red wine, with moderate…”
BackgroundSelf-citationDHA May Prevent Age-Related Dementia
Cole, G. M., & Frautschy, S. A. (2010) · Journal of Nutrition · doi:10.3945/jn.109.113910 · Cited by 164
Dyall, S. C., Michael, G. J., & Michael‐Titus, A. T. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22390 · Cited by 162
Luchsinger, J. A., Noble, J. M., & Scarmeas, N. (2007) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-007-0057-8 · Cited by 159
Nishikawa, M., Kimura, S., & Akaike, N. (1994) · The Journal of Physiology · doi:10.1113/jphysiol.1994.sp020051 · Cited by 155
Diet Intervention and Cerebrospinal Fluid Biomarkers in Amnestic Mild Cognitive Impairment
Bayer-Carter, J. L., Green, P. S., Montine, T. J., VanFossen, B., Baker, L. D., Watson, G. S., Bonner, L. M., Callaghan, M., Leverenz, J. B., Walter, B. K., et al. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.125 · Cited by 154
Crawford, M. A., Golfetto, I., Ghebremeskel, K., Min, Y., Moodley, T., Poston, L., Phylactos, A., Cunnane, S., & Schmidt, W. (2003) · Lipids · doi:10.1007/s11745-003-1065-1 · Cited by 150
Elgersma, Y., Sweatt, J. D., & Giese, K. P. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3622-04.2004 · Cited by 148
Genetic markers for diagnosis and pathogenesis of Alzheimer's disease
Kim, D., Yeo, S. H., Park, J.-M., Choi, J. Y., Lee, T.-H., Park, S. Y., Ock, M. S., Eo, J., Kim, H., & Cha, H. (2014) · Gene · doi:10.1016/j.gene.2014.05.031 · Cited by 146
Shatenstein, B., Kergoat, M., & Reid, I. (2007) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2007.09.008 · Cited by 144
Risk of developing dementia in people with diabetes and mild cognitive impairment
Velayudhan, L., Poppe, M., Archer, N., Proitsi, P., Brown, R. G., & Lovestone, S. (2010) · British Journal of Psychiatry · doi:10.1192/bjp.bp.109.067942 · Cited by 141
Dunstan, J. A., Mori, T. A., Barden, A. E., Beilin, L. J., Holt, P. G., Calder, P. C., Taylor, A. L., & Prescott, S. L. (2004) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601825 · Cited by 139
Delion, S., Chalon, S., Guilloteau, D., Lejeune, B., Besnard, J. C., & Durand, G. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37235-7 · Cited by 124
Changing Fatty Acid Content of Growth Cone Lipids Prior to Synaptogenesis
Martin, R. E., & Bazan, N. G. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08906.x · Cited by 117
Barceló‐Coblijn, G., Kitajka, K., Puskás, L. G., Hőgyes, E., Zvara, Á., Hackler, L., & Farkas, T. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(03)00064-7 · Cited by 114
Yoshida, Y., Yoshikawa, A., Kinumi, T., Ogawa, Y., Saito, Y., Ohara, K., Yamamoto, H., Imai, Y., & Niki, E. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.06.012 · Cited by 110
Wengreen, H. J. (2003) · PubMed · Cited by 109
Placental transfer of long-chain polyunsaturated fatty acids (LC-PUFA)
Koletzko, B., Larqué, E., & Demmelmair, H. (2007) · Journal of Perinatal Medicine · doi:10.1515/jpm.2007.030 · Cited by 107
Docosahexaenoic acid-containing phospholipid molecular species in brains of vertebrates
Farkas, T., Kitajka, K., Fodor, E., Csengeri, I., Lahdes, E., Yeo, Y. K., Krasznai, Z., & Halver, J. E. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120157297 · Cited by 104
Lopez, L. B., Kritz-Silverstein, D., & Barrett-Connor, E. (2011) · The Journal of nutrition, health and aging · doi:10.1007/s12603-011-0009-5 · Cited by 101
Bazan, N. G., Gordon, W. C., & Turco, E. (1992) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-3426-6_26 · Cited by 100
Ethyl-EPA in Alzheimer's disease—a pilot study
Boston, P. F., Bennett, A., Horrobin, D. F., & Bennett, C. N. (2004) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2004.07.001 · Cited by 97
Low Plasma N-3 Fatty Acids and Dementia in Older Persons: The InCHIANTI Study
Cherubini, A., Andres-Lacueva, C., Martin, A., Lauretani, F., Iorio, A. D., Bartali, B., Corsi, A., Bandinelli, S., Mattson, M. P., & Ferrucci, L. (2007) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/62.10.1120 · Cited by 95 · cited 1×
“The relationship between mental health disorder and omega-3 fatty acids has been shown by lower levels of omega-3 fatty acids in the erythrocyte membrane or plasma of the patients suffering from neurodegenerative disorder as compared with healthy people [95–97].”
ResultThe interplay between inflammation and neurodegeneration in CNS disease
Esiri, M. M. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.11.013 · Cited by 90
Badoer, E. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.07.005 · Cited by 87
Karczewska-Kupczewska, M., Kowalska, I., Nikołajuk, A., Adamska, A., Zielińska, M., Kamińska, N., Otziomek, E., Górska, M., & Strczkowski, M. (2012) · Diabetes Care · doi:10.2337/dc11-1295 · Cited by 76
Moreira, J. D., Knorr, L., Ganzella, M., Thomazi, A. P., de Souza, C. G., de Souza, D. G., Pitta, C. F., Souza, T. M. E., Wofchuk, S. T., Elisabetsky, E., et al. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.02.010 · Cited by 71
Time- and voltage-dependent block of delayed rectifier potassium channels by docosahexaenoic acid.
Poling, J. S., Karanian, J. W., Salem, N., & Vicini, S. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08551-7 · Cited by 70
Bazan, N. G., & Scott, B. L. (1990) · PubMed · Cited by 58
Lukiw, W. J., & Bazan, N. G. (2010) · Molecular Neurobiology · doi:10.1007/s12035-010-8126-4 · Cited by 54
Unresolved issues in the link between docosahexaenoic acid and Alzheimer's disease
Plourde, M., Fortier, M., Vandal, M., Tremblay‐Mercier, J., Freemantle, E., Bégin, M. E., Pifferi, F., & Cunnane, S. C. (2007) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2007.10.024 · Cited by 53
Maternal and umbilical fatty acid status in relation to maternal diet
Vriese, S. R. D., Matthys, C., Henauw, S. D., Backer, G. D., Dhont, M. A., & Christophe, A. B. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2002.0446 · Cited by 53
Fernandes, J. S., Mori, M., Ekuni, R., de Oliveira, R. M. W., & Milani, H. (2008) · Nutrition Research · doi:10.1016/j.nutres.2008.09.004 · Cited by 53
Chiu, C.-C., Frangou, S., Chang, C.-J., Chiu, W.-C., Liu, H.-C., Sun, I.-W., Liu, S.-I., Lu, M.-L., Chen, C.-H., Huang, S.-Y., et al. (2012) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.015784 · Cited by 47 · cited 1×
“The relationship between mental health disorder and omega-3 fatty acids has been shown by lower levels of omega-3 fatty acids in the erythrocyte membrane or plasma of the patients suffering from neurodegenerative disorder as compared with healthy people [95–97].”
ResultMahmoudi, M. J., Hedayat, M., Sharifi, F., Mirarefin, M., Nazari, N., Mehrdad, N., Ghaderpanahi, M., Tajalizadekhoob, Y., Badamchizade, Z., Larijani, B., et al. (2014) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/2251-6581-13-34 · Cited by 42
Primary Prevention of Alzheimer's Disease: Is It an Attainable Goal?
Han, J.-Y., & Han, S. (2014) · Journal of Korean Medical Science · doi:10.3346/jkms.2014.29.7.886 · Cited by 38
Cazzola, R., Rondanelli, M., Faliva, M. A., & Cestaro, B. (2012) · Experimental Gerontology · doi:10.1016/j.exger.2012.09.004 · Cited by 37
Immunology meets neuroscience – Opportunities for immune intervention in neurodegenerative diseases
Lynch, M. A., & Mills, K. H. G. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.05.013 · Cited by 37
Opie, R., Ralston, R. A., & Walker, K. Z. (2013) · Nutrition & Dietetics · doi:10.1111/1747-0080.12016 · Cited by 36
Lehrer, S., & Rheinstein, P. H. (2015) · American Journal of Alzheimer's Disease & Other Dementias® · doi:10.1177/1533317514545478 · Cited by 22
Thomas, J., Garg, M. L., & Smith, D. W. (2013) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2013.03.002 · Cited by 20
Self-citationA Guide to Evidence-based Integrative and Complementary Medicine
Kotsirilos, V., Vitetta, L., & Sali, A. (2011) · Cited by 18
DHA deficiency and Alzheimer's disease
Pomponi, M., & Pomponi, M. (2007) · Clinical Nutrition · doi:10.1016/j.clnu.2007.10.009 · Cited by 16
[Mechanism of improvement of spatial cognition with dietary docosahexaenoic acid].
Hashimoto, M., Tanabe, Y., Fujii, Y., Hagiwara, R., Yamasaki, H., & Shido, O. (2002) · PubMed · Cited by 8
Pharmacological Management of Alzheimer's Disease
Hecker, J. R., & Snellgrov, C. A. (2003) · Journal of Pharmacy Practice and Research · doi:10.1002/jppr200333124 · Cited by 4
Research works printed but not linked: 4
- 2009, Current Opinion in Investigational Drugs, 10, 1049
- 1990, Upsala Journal of Medical Sciences, Supplement, 97
- 2006, Journal of Nutrition, Health and Aging, 10, 386
- 2002, Nihon Yakurigaku Zasshi, 120, 54P
Cited by
Alzheimer's Disease: Treatment Strategies and Their Limitations.
Passeri, E., Elkhoury, K., Morsink, M., Broersen, K., Linder, M., Tamayol, A., Malaplate, C., Yen, F. T., & Arab-Tehrany, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213954 · Cited by 689
“Long-chain n-3 FA supplementation in the early stages of AD has shown promising potential [111].”
BackgroundDementia: What pharmacists need to know
Duong, S., Patel, T., & Chang, F. (2017) · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada · doi:10.1177/1715163517690745 · Cited by 304
The neuroprotective role of melatonin in neurological disorders
Alghamdi, B. S. (2018) · Journal of Neuroscience Research · doi:10.1002/jnr.24220 · Cited by 233
A review on the influence of nutraceuticals and functional foods on health
Vignesh, A., Amal, T. C., Sarvalingam, A., & Vasanth, K. (2024) · Food Chemistry Advances · doi:10.1016/j.focha.2024.100749 · Cited by 196
Schunck, W.-H., Konkel, A., Fischer, R., & Weylandt, K.-H. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.10.016 · Cited by 196
Metadata
- Authors
- Thomas, J., Thomas, C. J., Radcliffe, J., & Itsiopoulos, C.
- Affiliations
- La Trobe University (AU)
- Corresponding author
- Itsiopoulos, C.
- Venue
- BioMed Research International
- Publisher
- Wiley
- Published
- 2015
- Volume
- 2015
- Pages
- 1-13
- ISSN
- 1110-7243 (ISSN-L)
- 2314-6133
- 2314-6141
- PMC
- PMC4537710
- OpenAlex
- W1938773032
- Cited by
- 173
- References
- 100
- Citations by year
- 2026: 6 · 2025: 18 · 2024: 20 · 2023: 13 · 2022: 18 · 2021: 16 · 2020: 20 · 2019: 19 · 2018: 13 · 2017: 21 · 2016: 8 · 2015: 1
- FWCI
- 1.84
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- BioMed Research International (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- omega-3 fatty acids, Alzheimer's disease, neuroinflammation, docosahexaenoic acid, dietary supplementation, cognitive decline, dementia prevention, brain aging, long-chain polyunsaturated fatty acids, diet quality
- MeSH terms
- Aging, Alzheimer Disease, Diet, Humans, Fatty Acids, Omega-3, Dietary Supplements, Neurodegenerative Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.